XML 22 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Agreements and Transactions with VIE’s
3 Months Ended
Mar. 31, 2023
Agreements And Transactions With Vies  
Agreements and Transactions with VIE’s

Note 4 – Agreements and Transactions with VIE’s

 

The Company sells the INVOcell to its consolidated and unconsolidated VIEs and anticipates continuing to do so in the ordinary course of business. All intercompany transactions with consolidated entities are eliminated in the Company’s consolidated financial statements. Per ASC 323-10-35-8 the Company eliminates any sales to an unconsolidated VIE for INVOcell inventory that the VIE still has remaining on the books at period end.

 

The following table summarizes the Company’s transactions with VIEs:

  

   2023   2022 
  

Three Months Ended

March 31,

 
   2023   2022 
Bloom Invo, LLC          
INVOcell revenue  $4,500   $- 
Unconsolidated VIEs          
INVOcell revenue  $3,000   $7,500 

 

The Company had balances with VIEs as follows:

  

  

March 31,

2023

  

December 31,

2022

 
Bloom Invo, LLC          
Accounts receivable  $18,000    13,500 
Notes payable   471,637    468,031 
Unconsolidated VIEs          
Accounts receivable  $49,310    46,310